InMed Pharmaceuticals Inc.
For the period ended Mar 31, 2025. Filed May 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. LEGAL PROCEEDINGS
Except for the matters discussed in Note 11 of the unaudited condensed consolidated financial statements included in this Quarterly Report, the disclosure of which is incorporated in this Item 1. Part II of this Quarterly Report by reference, we are not presently involved in any active legal proceedings that we believe to be material to the Company. From time to time, we may be subject to various pending or threatened legal actions, claims and proceedings, including those that arise in the ordinary course of our business.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.